Aetion

About

Aetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.

New York,New York,United States
101 - 250
https://www.aetion.com

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: $27M
Industries: Analytics,Health Care,Software
Founded date: Jan 1, 2013
Number Of Employee: 101 - 250
Operating Status: Active
Legal Name: Aetion, Inc.

Aetion delivers real-world evidence (RWE) and outcomes-based analytics solutions to life sciences companies, payers, and at-risk providers.

With its patented rapid-cycle analytics technology, the Aetion Evidence Platform utilizes the everyday clinical and financial interactions of the healthcare system to unlock essential evidence about the effectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and top big data technologists, Aetion enables payers and providers to collaborate with biopharmaceutical and medical device companies in real-time to develop therapeutic insights and make smart choices in inpatient care.

Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Greenspring Associates, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, EDBI, Amgen Ventures, Johnson & Johnson Innovation — JJDC, Inc., UCB, and Horizon Health Services, Inc.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

$203.60M

Aetion has raised a total of $203.60M in funding over 2 rounds. Their latest funding was raised on May 11, 2021 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
May 11, 2021	Series C	$110M	5	Warburg Pincus	—	Detail
Aug 26, 2020	Series B	$19M	3	EDBI	—	Detail
Feb 5, 2019	Series B	$27M	9	—	—	Detail
Apr 11, 2018	Series B	$36.40M	5	New Enterprise Associates	—	Detail
Mar 20, 2017	Series A	$11.20M	3	Flare Capital Partners Lakestar	—	Detail

Investors

Number of Lead Investors

Number of Investors

5

18

Aetion is funded by 18 investors. Warburg Pincus and EDBI are the most recent investors.

Investor Name	Lead Investor	Funding Round
Warburg Pincus	Yes	Series C
EDBI	Yes	Series B
B Capital Group	—	Series C
Flare Capital Partners	—	Series C
Foresite Capital	—	Series C
New Enterprise Associates	—	Series C
Greenspring Associates	—	Series B
Johnson & Johnson Innovation – JJDC	—	Series B
Sanofi	—	Series B
UCB	—	Series B